Home
About Us
Help and Support
Subscribe
Company Analyst
Financial Analyst
Pipeline Analyst
Archives
Tools
Log In
Print this
Anti-TWEAK (TWEAK inhibitor) (BIIB023)
print preview
bookmark
share with colleague
General Information
Company
Biogen Idec Inc.
Description
Humanized mAb against tumor necrosis factor (TNF)-like weak inducer of apoptosis (TWEAK)
Molecular Target
TNF-like weak inducer of apoptosis (TWEAK)
Mechanism of Action
Antibody
Latest Stage of Development
Phase II
Indication
Lupus
Partner
Product Summary: Number of Indications in each Phase of Development by Disease Category
More
Product Details
Archive Items are loading
Set Email Alert
dummy